These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8937535)

  • 41. [Comparative assessment of treatment efficacy with lamotrigine (Lamictal) together with valproate and/or carbamazepine in patients with refractory epilepsy].
    Wierzba W; Wajgt A
    Neurol Neurochir Pol; 1997; 31(6):1133-46. PubMed ID: 9591300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lamotrigine: a review of antiepileptic efficacy.
    Yuen AW
    Epilepsia; 1994; 35 Suppl 5():S33-6. PubMed ID: 8039468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An active-control trial of lamotrigine monotherapy for partial seizures.
    Gilliam F; Vazquez B; Sackellares JC; Chang GY; Messenheimer J; Nyberg J; Risner ME; Rudd GD
    Neurology; 1998 Oct; 51(4):1018-25. PubMed ID: 9781523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.
    Gamble C; Williamson PR; Chadwick DW; Marson AG
    Neurology; 2006 May; 66(9):1310-7. PubMed ID: 16682660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lamotrigine: monotherapy in refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Apr; 148(4):153-8. PubMed ID: 9377849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.
    Baulac M; Leon T; O'Brien TJ; Whalen E; Barrett J
    Epilepsy Res; 2010 Sep; 91(1):10-9. PubMed ID: 20696552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials.
    Biton V; Shneker BF; Naritoku D; Hammer AE; Vuong A; Caldwell PT; Messenheimer JA
    Clin Drug Investig; 2013 May; 33(5):359-64. PubMed ID: 23475541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of Gabitril and Lamictal for drug-resistant epilepsy in adults.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():35-42. PubMed ID: 11977339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New antiepileptic drugs: comparison of key clinical trials.
    Cramer JA; Fisher R; Ben-Menachem E; French J; Mattson RH
    Epilepsia; 1999 May; 40(5):590-600. PubMed ID: 10386528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The use of lamotrigine monotherapy in children with newly diagnosed partial epilepsy].
    Sołowiej E; Sobaniec W; Kozik A; Ujma-Czapska B
    Neurol Neurochir Pol; 2000; 34 Suppl 1():129-41. PubMed ID: 10768153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.